BACKGROUND: The goal of the study was to analyse retrospectively the impact of risk factors for subarachnoid haemorrhage (SAH) on the size of ruptured intracranial aneurysms in order to identify variables that might influence the discrepancy between average sizes of ruptured and unruptured aneurysms. METHODS: The records and angiographies of 373 patients treated at our centre due to aneurysmal SAH between 2004 and December 2008 were retrospectively analysed. Modifiable and non-modifiable risk factors for SAH were correlated with exact measurement of aneurysm size using three-dimensional rotational digital subtraction angiographies (3D-DSA). RESULTS: Average maximum aneurysm diameter in patients with combined history of hypertension and cigarette smoking was 5.47±3.22 mm (95% CI 4.71 to 6.24); thus, significantly smaller (p<0.001) than in patients with hypertension only (6.27±3.28 mm, 95% CI 5.75 to 6.78), with cigarette smoking only (7.61±4.29 mm, 95% CI 6.43 to 8.79) and patients with no history for risk factors (8.08±4.73 mm, 95% CI 6.96 to 9.21). Odds ratio (OR) for aneurysm size less than 7 mm in patients with combined hypertension and cigarette smoking was 3.63 (95% CI 1.78 to 7.42), 3.09 (95% CI 1.95 to 4.92) in patients with hypertension only and 1.02 (95% CI 0.64 to 1.62) in patients with cigarette smoking only. CONCLUSIONS: The present analysis demonstrates a distinct correlation between hypertension, smoking and the size of ruptured aneurysms in SAH patients. Arterial hypertension and cigarette smoking appear to destabilise cerebral aneurysms' growth. Our data strongly suggest that these factors should also be considered when treatment indications for small unruptured aneurysms are discussed.
BACKGROUND: The goal of the study was to analyse retrospectively the impact of risk factors for subarachnoid haemorrhage (SAH) on the size of ruptured intracranial aneurysms in order to identify variables that might influence the discrepancy between average sizes of ruptured and unruptured aneurysms. METHODS: The records and angiographies of 373 patients treated at our centre due to aneurysmalSAH between 2004 and December 2008 were retrospectively analysed. Modifiable and non-modifiable risk factors for SAH were correlated with exact measurement of aneurysm size using three-dimensional rotational digital subtraction angiographies (3D-DSA). RESULTS: Average maximum aneurysm diameter in patients with combined history of hypertension and cigarette smoking was 5.47±3.22 mm (95% CI 4.71 to 6.24); thus, significantly smaller (p<0.001) than in patients with hypertension only (6.27±3.28 mm, 95% CI 5.75 to 6.78), with cigarette smoking only (7.61±4.29 mm, 95% CI 6.43 to 8.79) and patients with no history for risk factors (8.08±4.73 mm, 95% CI 6.96 to 9.21). Odds ratio (OR) for aneurysm size less than 7 mm in patients with combined hypertension and cigarette smoking was 3.63 (95% CI 1.78 to 7.42), 3.09 (95% CI 1.95 to 4.92) in patients with hypertension only and 1.02 (95% CI 0.64 to 1.62) in patients with cigarette smoking only. CONCLUSIONS: The present analysis demonstrates a distinct correlation between hypertension, smoking and the size of ruptured aneurysms in SAHpatients. Arterial hypertension and cigarette smoking appear to destabilise cerebral aneurysms' growth. Our data strongly suggest that these factors should also be considered when treatment indications for small unruptured aneurysms are discussed.
Authors: Johannes Platz; Erdem Güresir; Hartmut Vatter; Joachim Berkefeld; Volker Seifert; Andreas Raabe; Jürgen Beck Journal: Neurocrit Care Date: 2011-04 Impact factor: 3.210
Authors: Nima Etminan; Rita Dreier; Bruce A Buchholz; Kerim Beseoglu; Peter Bruckner; Christian Matzenauer; James C Torner; Robert D Brown; Hans-Jakob Steiger; Daniel Hänggi; R Loch Macdonald Journal: Stroke Date: 2014-04-29 Impact factor: 7.914
Authors: Philippe Bijlenga; Akio Morita; Nerissa U Ko; J Mocco; Sandrine Morel; Yuichi Murayama; Marieke J H Wermer; Robert D Brown Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210
Authors: Gabriel Rinkel; Nima Etminan; Katharina A M Hackenberg; Ale Algra; Rustam Al-Shahi Salman; Juhana Frösen; David Hasan; Seppo Juvela; David Langer; Philip Meyers; Akio Morita Journal: Neurocrit Care Date: 2019-06 Impact factor: 3.210